Our early investments in R&D, beginning over three decades ago has enabled us to make technology a key differentiator. Our core strength lies in our ability to excel in developing generics and technologically complex products through focused teams in formulations, process chemistry and analytical development.
Our Research Philosophy
Science is at the heart of Sun. Our scientists work closely with doctors, patients and the business development teams to generate innovative concepts and ideas to harness both, market needs and synergies across therapeutic areas. Whether it is specialty, generics, difficult to make technology intensive products, Active Pharmaceutical Ingredients (APIs) or Novel Drug Delivery Systems (NDDS), our scientists have the capability to deliver high quality products to fulfil the unmet need in the marketplace. Our R&D team comprises over 2,800 people working in six research centers across India, Israel, USA and Canada who have a passion for innovation and longing to provide better healthcare to humanity at large.
Our capabilities span the development of differentiated products including liposomal delivery, inhalers, lyophilised injections, nasal sprays besides developing controlled and modified release dosage forms. We are also pioneers in delivery systems of ophthalmology, cardiology, peptides, CNS and oncology.
Our knowledge in pharmaceutical research allows a rapid ramp-up of a diverse range of immediate and Novel Delivery Systems spanning oral, parenteral, topical and inhalation dosage forms. Our formulation expertise lies in the areas of taste masking, spray-drying, drug-layering, nano-milling among others. The ability to develop difficult-to-make, complex APIs by using latest technologies is the key differentiating factor of our research.
Strong Intellectual Property
Our research strategy and implementation are well supported by a strong intellectual property team having expertise and experience in chemistry, analytical techniques, dosage forms and global patent law. Sun files numerous patents every year to protect its intellectual property in markets of interest. We have close to 1600 patents to our credit.
Our R&D centres have been audited and approved by international regulatory authorities, including the US FDA and European authorities. The R&D centers at Vadodara, & Gurgaon in India are certified by the National GLP Compliance Monitoring Authority.